Pfizer’s Phase III Study Demostrate 95% Efficacy


One of the most likely vaccine candidates for the corona virus vaccine, the US pharmaceutical company Pfizer Inc, has a big claim on the vaccine. The company said that the Phase III study of our Covid-19 vaccine has met all the key points. The study reached 170 confirmed cases of Kovid-19. The vaccine candidate BNT163B2 (BNT162b2) showed a 95% effective onset 28 days after the first dose.

Disclaimer :- This post is independently published by the author. Infeed neither backs nor assumes liability for the opinions put forth by the author.

Share post:



More like this

73 Percent Population Devoid of Any Upliftment : Rahul Gandhi Roars in Patna

Congress leader Rahul Gandhi on Sunday alleged that the...

Pratapgarhi speaks against the demolition of 700-year-old mosque in Rajya Sabha

Congress leader Imran Pratapgarhi, in a poetic yet eloquent...

The Stealthy Rise of Autocracy: India’s Democratic Crisis Unveiled

Suspending MPs to strengthen Parliament security? Slow and steady...

After Bharat Jodo Yatra, Rahul Gandhi to go on Bharat Nyay Yatra from Jan 14 to March 20

The Congress on December 27 announced that party leader...